Adventurous investors have long sought out micro-cap stocks, attracted by the profit potential of starting on the...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
PHARMACEUTICAL INDUSTRY
The pharmaceutical industry operates under unique circumstances: Estimates of the cost to bring a single new drug to market range from $800 million to $1.2 billion, and on average, a patent’s life remaining upon FDA launch approval is only eight years. Thus, achieving the highest level of performance is critical to pharmaceutical companies. This topic is dedicated to marketing, market research, business operations, and management issues specific to the pharmaceutical industry.
Pharmaceutical Industry is part of Business Exchange, suggested by
Ken Rhines.
This topic contains
2,136 news
and
781 blog
items.
Read updated news, blogs, and resources about Pharmaceutical Industry. Find user-submitted articles and reactions on Pharmaceutical Industry from
like-minded professionals.
Most Active
The most active stories in this topic based on user activity.
Radiopharmaceuticals imply the usage of radiation for non-invasive treatment and diagnosis of various diseases.
Stem cell companies have languished long enough in micro-cap territory. The industry is now approaching highly visible...
Markets are not efficientat least not in the short term. WBB Securities President Stephen Brozak admits to frustration...
What catalysts in the drug development process move biotech company stocks? The savvy investor must know what steps in...
In January 2013, The Life Sciences Report debuted its biotech Watchlist, which outlined ideas for investors keyed to...
Girish Malhotra explains how to exploit chemical properties to optimize API development
Dick Huebner knows what he wants. He's looking for biotech companies that can make it very big from a near zero-base...
Israel's Leading Life Science Consulting | Biotech Company Valuation | Pharma Due Diligence
There is no one way physicians prefer to interact with a medical company. Many factors influence the physician’s view...
Bausch + Lomb Signs Exclusive License Agreement with Paragon BioTeck for Phenylephrine : MADISON, N.J. and TIGARD, Ore.
Barry Wise, Ph.D, discusses his chemometrics classes and how we can get the best from our calibration data while...
ATLANTA, Ga., Feb. 7, 2013 (SEND2PRESS NEWSWIRE) -- CMI, a leader in marketing research services and insight, announced...
Naysayers may harp on the low market valuations of stem cell companies, but Geoff MacKay has an insider's perspective.
One of the key factors contributing to this market growth is the huge patient population with various neurological...
This Swot Analysis bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the...
Could the quantum computing revolution transform drug development, are there new approaches for...
ATLANTA, Ga., March 7, 2013 (SEND2PRESS NEWSWIRE) -- CMI and Pfizer will co-present 'Engaging Stakeholders with A Story...
With the progression of infrastructure, China Medical care Market is coming into a new era of growth. A large...
Due to an integrated research system, robust growth, Singapore has emerged as a choice biomedical location.
he orthobiologics market will see significant growth during the period 2012-2022. Growth will be driven primarily by...
Lars Nørgaard, Affiliated Professor, University of Copenhagen, presents a brief insight into the wealth of data...
Israel's Leading Life Science Consulting | Biotech Company Valuation | Pharma Due Diligence
Top Sources: Pharmaceutical Industry
- pharmachemicalscoatings.blogspot.com
- BusinessWeek
- bloomberg.com
- Reuters
- New York Times
- srcomblog.wordpress.com
- Industry Week
- pharmatching.com
- send2press.com
- myharvardnews.com
Tweets on this Topic














account